JPWO2008120717A1 - Liquid nutrition composition containing sodium in high concentration and method for producing the same - Google Patents
Liquid nutrition composition containing sodium in high concentration and method for producing the same Download PDFInfo
- Publication number
- JPWO2008120717A1 JPWO2008120717A1 JP2009507517A JP2009507517A JPWO2008120717A1 JP WO2008120717 A1 JPWO2008120717 A1 JP WO2008120717A1 JP 2009507517 A JP2009507517 A JP 2009507517A JP 2009507517 A JP2009507517 A JP 2009507517A JP WO2008120717 A1 JPWO2008120717 A1 JP WO2008120717A1
- Authority
- JP
- Japan
- Prior art keywords
- sodium
- liquid
- composition
- food
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 91
- 239000000203 mixture Substances 0.000 title claims abstract description 88
- 239000007788 liquid Substances 0.000 title claims abstract description 83
- 239000011734 sodium Substances 0.000 title claims abstract description 66
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 title claims abstract description 65
- 229910052708 sodium Inorganic materials 0.000 title claims abstract description 65
- 230000035764 nutrition Effects 0.000 title claims description 17
- 238000004519 manufacturing process Methods 0.000 title claims description 6
- 235000013305 food Nutrition 0.000 claims abstract description 58
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 43
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 43
- 150000002632 lipids Chemical class 0.000 claims abstract description 24
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 22
- 235000021056 liquid food Nutrition 0.000 claims description 26
- 159000000000 sodium salts Chemical class 0.000 claims description 26
- 150000007524 organic acids Chemical class 0.000 claims description 17
- 239000007864 aqueous solution Substances 0.000 claims description 16
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 15
- 235000015872 dietary supplement Nutrition 0.000 claims description 10
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 claims description 6
- 235000015097 nutrients Nutrition 0.000 claims description 6
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 5
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 5
- 235000015165 citric acid Nutrition 0.000 claims description 5
- 239000001630 malic acid Substances 0.000 claims description 5
- 235000011090 malic acid Nutrition 0.000 claims description 5
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 claims description 3
- 239000000174 gluconic acid Substances 0.000 claims description 3
- 235000012208 gluconic acid Nutrition 0.000 claims description 3
- -1 organic acid sodium salt Chemical class 0.000 claims description 2
- MSXHSNHNTORCAW-GGLLEASOSA-M sodium;(2s,3s,4s,5r,6s)-3,4,5,6-tetrahydroxyoxane-2-carboxylate Chemical compound [Na+].O[C@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O MSXHSNHNTORCAW-GGLLEASOSA-M 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 1
- 230000002776 aggregation Effects 0.000 abstract description 15
- 238000004220 aggregation Methods 0.000 abstract description 15
- 238000001879 gelation Methods 0.000 abstract description 12
- 230000000704 physical effect Effects 0.000 abstract description 10
- 235000018102 proteins Nutrition 0.000 description 36
- 235000014633 carbohydrates Nutrition 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 230000000694 effects Effects 0.000 description 8
- 239000002245 particle Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000001509 sodium citrate Substances 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 5
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 5
- 229940038773 trisodium citrate Drugs 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 4
- 230000009469 supplementation Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 102000011632 Caseins Human genes 0.000 description 2
- 108010076119 Caseins Proteins 0.000 description 2
- 208000028399 Critical Illness Diseases 0.000 description 2
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000011449 brick Substances 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- MSJMDZAOKORVFC-SEPHDYHBSA-L disodium fumarate Chemical compound [Na+].[Na+].[O-]C(=O)\C=C\C([O-])=O MSJMDZAOKORVFC-SEPHDYHBSA-L 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 235000019265 sodium DL-malate Nutrition 0.000 description 2
- HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 2
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 2
- 235000010378 sodium ascorbate Nutrition 0.000 description 2
- 229960005055 sodium ascorbate Drugs 0.000 description 2
- 229940080237 sodium caseinate Drugs 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000004320 sodium erythorbate Substances 0.000 description 2
- 235000010352 sodium erythorbate Nutrition 0.000 description 2
- 235000019294 sodium fumarate Nutrition 0.000 description 2
- 239000000176 sodium gluconate Substances 0.000 description 2
- 235000012207 sodium gluconate Nutrition 0.000 description 2
- 229940005574 sodium gluconate Drugs 0.000 description 2
- WPUMTJGUQUYPIV-UHFFFAOYSA-L sodium malate Chemical compound [Na+].[Na+].[O-]C(=O)C(O)CC([O-])=O WPUMTJGUQUYPIV-UHFFFAOYSA-L 0.000 description 2
- 235000010344 sodium nitrate Nutrition 0.000 description 2
- 239000004317 sodium nitrate Substances 0.000 description 2
- 239000001433 sodium tartrate Substances 0.000 description 2
- 229960002167 sodium tartrate Drugs 0.000 description 2
- 235000011004 sodium tartrates Nutrition 0.000 description 2
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 2
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 235000019263 trisodium citrate Nutrition 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010021036 Hyponatraemia Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 108010070551 Meat Proteins Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000006916 protein interaction Effects 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- JXKPEJDQGNYQSM-UHFFFAOYSA-M sodium propionate Chemical compound [Na+].CCC([O-])=O JXKPEJDQGNYQSM-UHFFFAOYSA-M 0.000 description 1
- 235000010334 sodium propionate Nutrition 0.000 description 1
- 239000004324 sodium propionate Substances 0.000 description 1
- 229960003212 sodium propionate Drugs 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/66—Proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/3526—Organic compounds containing nitrogen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pediatric Medicine (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本発明は、タンパク質と、脂質と、糖質とを含んでなり、かつ、組成物の熱量が1kcal/ml以上である、液状栄養組成物であって、組成物中のタンパク質濃度が30〜100mg/mlであり、かつ、組成物のナトリウム濃度が2mg/mlよりも高いことを特徴とする液状栄養組成物に関する。本発明によれば、タンパク質とナトリウムが高濃度で共存する状態でもゲル化や凝集などが起こることなく、良好な熱安定性や物性を維持できる。したがって、本発明によれば、良好な熱安定性や物性を有する、ナトリウムを高濃度で含む高タンパクの液状栄養食品を提供することができる。The present invention is a liquid nutritional composition comprising a protein, a lipid, and a carbohydrate, and the calorie of the composition is 1 kcal / ml or more, wherein the protein concentration in the composition is 30 to 100 mg. The liquid nutritional composition is characterized in that the sodium concentration of the composition is higher than 2 mg / ml. According to the present invention, good thermal stability and physical properties can be maintained without causing gelation or aggregation even in a state where protein and sodium coexist at a high concentration. Therefore, according to the present invention, it is possible to provide a high-protein liquid nutritional food that has good thermal stability and physical properties and contains sodium at a high concentration.
Description
本願は、先行する日本国特許出願である特願2007−090052号(出願日:2007年3月30日)に基づくものであって、その優先権の利益を主張するものであり、その開示内容全体は参照することにより、ここに組み込まれる。 This application is based on Japanese Patent Application No. 2007-090052 (filing date: March 30, 2007), which is a prior Japanese patent application, and claims the benefit of its priority. The entirety of which is incorporated herein by reference.
発明の分野
本発明は、流動食や医療食などに好適に用いることができる、ナトリウムを高濃度で含む液状栄養組成物に関する。より詳しくは本発明は、タンパク質とナトリウムとを高濃度で含む一方で、ゲル化や凝集などを起こさない、熱安定性や物性が良好な液状栄養組成物に関する。 FIELD OF THE INVENTION The present invention relates to a liquid nutritional composition containing sodium at a high concentration that can be suitably used for liquid foods, medical foods, and the like. More specifically, the present invention relates to a liquid nutritional composition having good thermal stability and physical properties that does not cause gelation or aggregation while containing protein and sodium at a high concentration.
背景技術
市販されている液状栄養食品(通常の流動食・医療食、経腸栄養剤など)においては、通常、そのナトリウム(Na)濃度は低く設定されている。例えば、典型的な液状栄養食品では、ナトリウム濃度は高い場合であっても、1mg/ml程度である。このとき、液状栄養食品の熱量(カロリーまたはエネルギー値)は1kcal/ml以上、例えば、1〜2kcal/ml程度である。 Background Art In commercially available liquid nutritional foods (ordinary liquid foods / medical foods, enteral nutrients, etc.), the sodium (Na) concentration is usually set low. For example, in a typical liquid nutritional food, even if the sodium concentration is high, it is about 1 mg / ml. At this time, the caloric value (calorie or energy value) of the liquid nutritional food is 1 kcal / ml or more, for example, about 1 to 2 kcal / ml.
病院や施設などの医療現場では、このような通常の液状栄養食品を飲用している患者が低ナトリウム血症となることがある。このため、医療現場では、患者が摂取する直前に、通常の液状栄養食品へ食塩を添加して使用することが行われている。例えば、文献(静脈経腸栄養、Vol.19 増刊号、P.79(2004))には、液状栄養食品などによる経腸栄養の期間が20日以上に及ぶような重症患者では、その殆どが食塩(ナトリウム)の補充(平均で5.1g±2.8g/日)を必要としたという報告がある。ここでは、通常の液状栄養食品に、摂取直前に食塩を添加して、患者へ摂取させている。 In medical settings such as hospitals and facilities, patients who are drinking such normal liquid nutritional foods may develop hyponatremia. For this reason, in a medical field, adding salt to a normal liquid nutritional food and using it just before a patient ingests is performed. For example, in the literature (intravenous enteral nutrition, Vol.19 special issue, P.79 (2004)), most of the critically ill patients whose duration of enteral nutrition with liquid nutritional foods is 20 days or more are almost all. There is a report that sodium (sodium) supplementation was required (on average 5.1 g ± 2.8 g / day). Here, salt is added to a normal liquid nutritional food just before ingestion and the patient is ingested.
このように、医療現場などでは、ナトリウムを高濃度で含む液状栄養食品(例えば、ナトリウムの含量の高い流動食および医療食など)の必要性および要望は高いといえる。 Thus, it can be said that the necessity and demand for liquid nutritional foods (for example, liquid foods and medical foods with a high sodium content) containing sodium at a high concentration are high in the medical field.
ナトリウムを比較的高濃度で含む液状栄養食品としては、実際に、熱量1kcal/mlの食品において、ナトリウムが2mg/ml(食塩に換算して5.1mg/ml)含まれている液状栄養食品が市販されている。また例えば、特開2004−97116号公報には、リン酸ナトリウムおよびクエン酸ナトリウムを含む液状飲食品が記載されている。
しかしながら、これら従来の食品のナトリウム濃度では、重症患者へ積極的にナトリウムを補給する必要性を考慮すると、まだ十分とは言えない。As a liquid nutritional food containing a relatively high concentration of sodium, a liquid nutritional food containing 2 mg / ml of sodium (5.1 mg / ml in terms of salt) is actually included in a food with a calorific value of 1 kcal / ml. It is commercially available. Further, for example, Japanese Patent Application Laid-Open No. 2004-97116 describes a liquid food and drink containing sodium phosphate and sodium citrate.
However, the sodium concentrations of these conventional foods are still not sufficient when considering the need to actively supplement sodium in critically ill patients.
一方で、ナトリウムを2mg/mlよりも高濃度で含む液状栄養食品は、本発明者の知る限り、製品として、これまで存在していなかった。これは、タンパク質を高濃度で含む水溶液に、ナトリウム塩を高濃度となるように添加すると、通常、タンパク質が変性してしまうため、製品としてナトリウムを高濃度で含む液状栄養食品を製造し維持することが困難であったからと考えられる。すなわち、流動食などのようにタンパク質を高濃度で含む水溶液に、高濃度となるよう食塩などのナトリウム塩を加えると、タンパク質がゲル化して水溶液の粘度が増加してしまったり、タンパク質が凝集して沈殿してしまったりする現象が起こり、製品の安定性や特性上、問題となる。 On the other hand, a liquid nutritional food containing sodium at a concentration higher than 2 mg / ml has not existed as a product so far as the present inventors know. This is because when a sodium salt is added to an aqueous solution containing a high concentration of protein, the protein is usually denatured, so that a liquid nutritional food containing a high concentration of sodium is produced and maintained as a product. This is thought to be difficult. That is, when sodium salt such as sodium chloride is added to an aqueous solution containing a high concentration of protein such as liquid food, the protein gels and the viscosity of the aqueous solution increases, or the protein aggregates. This may cause a problem in terms of stability and characteristics of the product.
このようなタンパク質のゲル化や凝集を防ぐ手段として、食塩などのナトリウム塩を添加する代わりに、ナトリウムカゼイネートを使用することが考えられる。しかしながら、ナトリウムカゼイネートを多量に含む水溶液(調合液など)では、その水溶液自体の粘度が極端に増加してしまい、結果として、製品の良好な熱安定性(耐熱性)および物性を確保するのが困難となる。 As a means for preventing such gelation and aggregation of protein, it is conceivable to use sodium caseinate instead of adding sodium salt such as sodium chloride. However, in an aqueous solution containing a large amount of sodium caseinate (prepared solution, etc.), the viscosity of the aqueous solution itself increases extremely, and as a result, good thermal stability (heat resistance) and physical properties of the product are ensured. It becomes difficult.
このため、依然として、ナトリウムを従来よりも高濃度で含む液状栄養食品の開発が望まれていた。 For this reason, the development of a liquid nutritional food containing sodium at a higher concentration than before has been desired.
本発明者は今般、タンパク質を高濃度で含む水溶液へ加えるナトリウムの主要なナトリウム供給源として、有機酸のナトリウム塩を用いることにより、タンパク質とナトリウムとが高濃度で共存する状態であっても、ゲル化や凝集などを起こすことなく、良好な熱安定性や物性を維持できることに、予想外にも成功した。本発明は、かかる知見に基づくものである。 The present inventor has now used a sodium salt of an organic acid as a main sodium source of sodium added to an aqueous solution containing a protein at a high concentration, so that even if the protein and sodium coexist at a high concentration, Unexpectedly successful in maintaining good thermal stability and physical properties without causing gelation or aggregation. The present invention is based on such knowledge.
よって本発明は、タンパク質とナトリウムとを高濃度で含むと同時に、タンパク質のゲル化や凝集などを起こさず、良好な熱安定性や物性を有する液状栄養組成物を提供することを目的とする。 Therefore, an object of the present invention is to provide a liquid nutritional composition that has good heat stability and physical properties without containing protein and sodium at high concentrations and at the same time causing protein gelation and aggregation.
本発明による液状栄養組成物は、タンパク質と、脂質と、糖質とを含んでなり、かつ、組成物の熱量が1kcal/ml以上である、液状栄養組成物であって、組成物中のタンパク質濃度が30〜100mg/mlであり、かつ、組成物のナトリウム濃度が2mg/mlよりも高いことを特徴とするものである。 The liquid nutritional composition according to the present invention is a liquid nutritional composition comprising protein, lipid, and carbohydrate, and the calorie of the composition is 1 kcal / ml or more, wherein the protein in the composition The concentration is 30 to 100 mg / ml, and the sodium concentration of the composition is higher than 2 mg / ml.
本発明の好ましい態様によれば、本発明による液状栄養組成物は、タンパク質と、脂質と、糖質と、有機酸のナトリウム塩とを含んでなるものである。より好ましくは、有機酸のナトリウム塩は、クエン酸、リンゴ酸もしくはグルコン酸のナトリウム塩、またはそれらの混合物である。 According to a preferred embodiment of the present invention, the liquid nutritional composition according to the present invention comprises a protein, a lipid, a carbohydrate, and a sodium salt of an organic acid. More preferably, the sodium salt of the organic acid is citric acid, malic acid or gluconic acid sodium salt, or a mixture thereof.
本発明の一つの好ましい態様によれば、本発明による液状栄養組成物の熱量は、1〜3kcal/mlである。 According to one preferred embodiment of the present invention, the calorific value of the liquid nutritional composition according to the present invention is 1 to 3 kcal / ml.
本発明の一つのより好ましい態様によれば、本発明による液状栄養組成物はさらに、脂質を20〜100mg/ml、かつ、糖質を50〜350mg/mlで含む。 According to one more preferred embodiment of the present invention, the liquid nutritional composition according to the present invention further comprises 20 to 100 mg / ml of lipid and 50 to 350 mg / ml of carbohydrate.
本発明の別の好ましい態様によれば、本発明による液状栄養組成物は、食品として提供される。本発明の別のより好ましい態様によれば、本発明による液状栄養組成物は、流動食、医療食、経腸栄養剤、または栄養補給飲食品として提供される。 According to another preferred embodiment of the present invention, the liquid nutritional composition according to the present invention is provided as a food. According to another more preferable aspect of the present invention, the liquid nutrition composition according to the present invention is provided as a liquid food, a medical food, an enteral nutrient, or a nutritional supplement food or drink.
本発明による前記液状栄養組成物の製造方法は、タンパク質と、脂質と、糖質とを含む水溶液に、有機酸のナトリウム塩を加えることによって、液状栄養組成物中のナトリウム濃度を2mg/mlより高い濃度とすることを含んでなる。 In the method for producing the liquid nutritional composition according to the present invention, by adding a sodium salt of an organic acid to an aqueous solution containing protein, lipid, and saccharide, the sodium concentration in the liquid nutritional composition is more than 2 mg / ml. High concentration.
本発明の別の態様によれば、本発明による液状栄養食品は、熱量が1kcal/ml以上で、タンパク質、脂質、糖質を含み、ナトリウムを2mg/mlよりも高濃度で含むことを特徴とする液状栄養食品である。このとき主要なナトリウム供給源として、有機酸のナトリウム塩を用いることが好ましい。また、このとき、該液状栄養食品は、タンパク質を30〜100mg/ml、脂質を20〜100mg/ml、および、糖質を50〜350mg/mlを含む。 According to another aspect of the present invention, the liquid nutritional food according to the present invention has a calorific value of 1 kcal / ml or more, contains protein, lipid, carbohydrate, and contains sodium at a concentration higher than 2 mg / ml. It is a liquid nutritional food. At this time, it is preferable to use a sodium salt of an organic acid as a main sodium source. At this time, the liquid nutritional food contains 30 to 100 mg / ml of protein, 20 to 100 mg / ml of lipid, and 50 to 350 mg / ml of carbohydrate.
本発明によれば、タンパク質とナトリウムを高濃度で含みながら、ゲル化や凝集などを起こさず、良好な熱安定性や物性を有する液状栄養組成物を提供することができる。従来、要介護者など患者が流動食を飲用する直前に、液状栄養食品へナトリウム塩を添加して調製していたが、この際、ゲル化や凝集などを完全には避けることはできなかった。本発明においては、液状栄養食品へ予めナトリウムが高濃度で含まれているため、ゲル化や凝集の発生など、流動食摂取における危険因子を予め排除することができる。このため、安全かつ安心して使用することができる。また、本発明による液状栄養組成物を、臨床現場などで用いることで、流動食などへナトリウム塩を添加する現場での作業が不要となり、介護者の作業性を飛躍的に向上することができる。さらにナトリウムの補給は、夏期に頻繁に実施されることが多いため、これら臨床現場における、介護者の作業負担を大幅に軽減できる。 According to the present invention, it is possible to provide a liquid nutritional composition having good thermal stability and physical properties without causing gelation or aggregation while containing protein and sodium at a high concentration. Conventionally, patients such as those requiring care were prepared by adding sodium salt to liquid nutritional foods immediately before drinking liquid foods, but at this time, gelation and aggregation could not be completely avoided. . In the present invention, since the liquid nutritional food contains sodium in a high concentration in advance, risk factors such as gelation and aggregation may be eliminated in advance. For this reason, it can be used safely and safely. Moreover, the use of the liquid nutritional composition according to the present invention in a clinical setting or the like eliminates the need to add a sodium salt to a liquid food or the like, and can greatly improve the workability of a caregiver. . Furthermore, since sodium supplementation is frequently performed in the summer, the burden on the caregiver in these clinical settings can be greatly reduced.
液状栄養組成物
本発明による液状栄養組成物は、前記したように、タンパク質と、脂質と、糖質とを含んでなり、かつ、組成物の熱量が1kcal/ml以上である、液状栄養組成物であって、組成物のナトリウム濃度が2mg/mlよりも高いことを特徴とするものである。ここで、液状とは、本発明による組成物が、水を主成分とし、かつ、タンパク質、脂質、糖質、ナトリウムが水に溶解している水溶液であることを意味する。 Liquid Nutrient Composition As described above, the liquid nutrition composition according to the present invention comprises protein, lipid, and carbohydrate, and the calorific value of the composition is 1 kcal / ml or more. The sodium concentration of the composition is higher than 2 mg / ml. Here, the liquid state means that the composition according to the present invention is an aqueous solution in which water is a main component and proteins, lipids, carbohydrates, and sodium are dissolved in water.
本発明による液状栄養組成物は、主として栄養補給を目的としたものであり、単独で、そのまま食品として摂取する他、市販の流動食などの栄養食品もしくは栄養補給剤と任意の割合で混合して、熱量(カロリー)や濃度を調節しながら、患者もしくは健常者向けに推奨される、タンパク質、脂質、糖質、ビタミン類、およびミネラル類の摂取量の範囲を維持しつつ、個々の使用者(もしくは患者)向けの食品または栄養補給剤(流動食、医療食、経腸栄養剤など)とし摂取することができる。
このとき、タンパク質、脂質、および糖質などの前記摂取量を決定する目的で、例えば、「日本人の食事摂取基準」(日本国厚生労働省による)などのような、健康や保健の観点から各国の政府機関や公的機関、学術機関などが公表または推奨している基準を適宜参照することができる。The liquid nutritional composition according to the present invention is mainly intended for nutritional supplementation, and is taken alone as a food, or mixed with a nutritional food such as a commercially available liquid food or a nutritional supplement at an arbitrary ratio. , While adjusting the calorie and concentration, and maintaining the range of protein, lipid, carbohydrate, vitamins, and mineral intakes recommended for patients and healthy individuals, Alternatively, it can be taken as a food for a patient) or a nutritional supplement (liquid food, medical food, enteral nutrition, etc.).
At this time, for the purpose of determining the intake amount of proteins, lipids, carbohydrates, etc., for example, from the viewpoint of health and health, such as “Japanese dietary intake standards” (by the Ministry of Health, Labor and Welfare of Japan). Standards published or recommended by government agencies, public institutions, academic institutions, etc. can be referred to as appropriate.
本発明による液状栄養組成物はまた、従来品においては含有量が少ないナトリウムについて、ナトリウムの補給を目的としたものでもある。このため、本発明による液状栄養組成物を単独で、そのまま摂取する他、市販の流動食など栄養食品もしくは栄養補給剤と任意の割合で混合することにより、ナトリウム濃度を調節しながら、個々の使用者(もしくは患者)向けの食品または栄養補給剤とし摂取することができる。 The liquid nutritional composition according to the present invention is also intended to replenish sodium for sodium, which has a low content in conventional products. For this reason, in addition to ingesting the liquid nutritional composition according to the present invention alone, it can be used for individual use while adjusting the sodium concentration by mixing it with a nutritional food or nutritional supplement such as a commercially available liquid food at an arbitrary ratio. It can be taken as a food or nutritional supplement for the elderly (or patient).
熱量
本発明の液状栄養組成物の熱量としては、好ましくは1〜3kcal/ml、より好ましくは1〜2.5kcal/ml、さらに好ましくは1〜2kcal/ml、さらにより好ましくは1.5〜2kcal/mlである。一般的に、液状栄養組成物の熱量が高いと、タンパク質等の成分の濃度が高くなるため、ゲル化や凝集が起こり易くなる。すなわち、液状栄養組成物の熱量が高すぎると、本発明の効果や作用が発揮されても、ゲル化や凝集を完全に抑制することは困難となる。一方、液状栄養組成物の熱量が低いと、ゲル化や凝集は起こり難くなるものの、本発明において望まれる効果や作用が発揮され難くなる。このため、液状栄養組成物の熱量を適切なレベルに調整することが望ましいと言える。
本発明の組成物が上記熱量を達成するためには、例えば、組成物中において、例えば、タンパク質を30〜100mg/ml、脂質を20〜100mg/ml、および糖質を50〜350mg/mlの各範囲となるように調整することが好ましい。 The calorific value of the liquid nutritional composition of the present invention is preferably 1 to 3 kcal / ml, more preferably 1 to 2.5 kcal / ml, still more preferably 1 to 2 kcal / ml, and even more preferably 1.5 to 2 kcal. / Ml. Generally, when the calorie | heat amount of a liquid nutrition composition is high, since the density | concentration of components, such as protein, will become high, gelatinization and aggregation will occur easily. That is, when the calorie | heat amount of a liquid nutrition composition is too high, even if the effect and effect | action of this invention are exhibited, it will become difficult to suppress gelatinization and aggregation completely. On the other hand, when the calorie | heat amount of a liquid nutritional composition is low, although gelatinization and aggregation will not occur easily, the effect and effect | action desired in this invention will become difficult to be exhibited. For this reason, it can be said that it is desirable to adjust the calorie | heat amount of a liquid nutrition composition to a suitable level.
In order for the composition of the present invention to achieve the above calorific value, for example, in the composition, for example, protein is 30 to 100 mg / ml, lipid is 20 to 100 mg / ml, and carbohydrate is 50 to 350 mg / ml. It is preferable to adjust so that it may become each range.
タンパク質
本発明において用いられるタンパク質は、食品用途に使用可能なものであれば特に限定されず、いずれのものであっても良い。このようなタンパク質の具体例としては、乳タンパク質、肉タンパク質などの動物性タンパク質;大豆タンパク質などの植物性タンパク質;ペプチドやアミノ酸を含む動物性もしくは植物性のタンパク質の酵素分解物などが挙げられる。これらは、単独で使用しても、任意に組み合わせて使用しても良い。
なお、タンパク質の液状栄養組成物に占める熱量(エネルギー量)は、全エネルギー量の3〜10重量%であることが好ましい。 Protein The protein used in the present invention is not particularly limited as long as it can be used for food applications, and any protein may be used. Specific examples of such proteins include animal proteins such as milk protein and meat protein; vegetable proteins such as soy protein; and enzymatic degradation products of animal or vegetable proteins containing peptides and amino acids. These may be used alone or in any combination.
In addition, it is preferable that the calorie | heat amount (energy amount) which occupies for the liquid nutrition composition of protein is 3 to 10 weight% of the total energy amount.
本発明において、組成物中におけるタンパク質の濃度は、好ましくは30〜90mg/ml、より好ましくは35〜80mg/ml、さらに好ましくは40〜75mg/mlである。 In the present invention, the concentration of the protein in the composition is preferably 30 to 90 mg / ml, more preferably 35 to 80 mg / ml, still more preferably 40 to 75 mg / ml.
脂質
本発明において用いられる脂質は、食品用途に使用可能なものであれば特に限定されず、いずれのものであっても良い。このような脂質の具体例としては、大豆油、コーン油、綿実油、シソ油、ヤシ油、菜種油などの植物油;牛脂、豚脂、魚油などの動物油;合成トリグリセリドなどが挙げられる。これらは、単独で使用しても、任意に組み合わせて使用しても良い。
なお、脂質の液状栄養組成物に占めるエネルギー量は、全エネルギー量の2〜10重量%であることが好ましい。 Lipid The lipid used in the present invention is not particularly limited as long as it can be used for food applications, and any lipid may be used. Specific examples of such lipids include vegetable oils such as soybean oil, corn oil, cottonseed oil, perilla oil, coconut oil and rapeseed oil; animal oils such as beef tallow, lard and fish oil; synthetic triglycerides and the like. These may be used alone or in any combination.
In addition, it is preferable that the energy amount which occupies for the liquid nutrient composition of a lipid is 2 to 10 weight% of a total energy amount.
本発明において、組成物中における脂質の濃度は、好ましくは20〜90mg/ml、より好ましくは20〜80mg/ml、さらに好ましくは25〜75mg/mlである。 In the present invention, the lipid concentration in the composition is preferably 20 to 90 mg / ml, more preferably 20 to 80 mg / ml, still more preferably 25 to 75 mg / ml.
糖質
本発明において用いられる糖質は、食品用途に使用可能なものであれば特に限定されず、いずれのものであっても良い。このような糖質の具体例としては、ブドウ糖、果糖などの単糖類;デンプン、デキストリンなどの多糖類;マルトース、乳糖などの二糖類を含むオリゴ糖類などが挙げられる。これらは、単独で使用しても、任意に組み合わせて使用しても良い。
なお、糖質の液状栄養組成物に占めるエネルギー量は、全エネルギー量の5〜35重量%であることが好ましい。 Carbohydrate The sugar used in the present invention is not particularly limited as long as it can be used for food applications, and any sugar may be used. Specific examples of such saccharides include monosaccharides such as glucose and fructose; polysaccharides such as starch and dextrin; oligosaccharides including disaccharides such as maltose and lactose. These may be used alone or in any combination.
In addition, it is preferable that the energy amount which occupies for the liquid nutritional composition of saccharides is 5 to 35 weight% of the total energy amount.
本発明において、組成物中における糖質の濃度は、好ましくは80〜320mg/ml、より好ましくは100〜300mg/ml、さらに好ましくは120〜280mg/mlである。 In the present invention, the carbohydrate concentration in the composition is preferably 80 to 320 mg / ml, more preferably 100 to 300 mg / ml, and still more preferably 120 to 280 mg / ml.
ナトリウム
本発明による液状栄養組成物のナトリウム濃度としては、好ましくは2.2〜8mg/ml、より好ましくは2.4〜7mg/ml、さらに好ましくは3〜7mg/ml、さらにより好ましくは3〜6mg/mlである。一般的に、タンパク質を高濃度で含む液状栄養組成物において、ナトリウム濃度を高くすると、ゲル化や凝集が起こり易くなる。すなわち、該栄養組成物のナトリウム濃度が高すぎると、本発明の効果や作用が発揮されても、ゲル化や凝集を完全に抑制することは困難となる。一方、該栄養組成物のナトリウム濃度が低いと、ゲル化や凝集は起こり難くなるものの、本発明において望まれる効果や作用が発揮され難くなる。このため、液状栄養組成物のナトリウム濃度を、タンパク質の濃度との関係を考慮しつつ、適切なレベルに調整することが望ましいと言える。 Sodium The sodium concentration of the liquid nutritional composition according to the present invention is preferably 2.2 to 8 mg / ml, more preferably 2.4 to 7 mg / ml, still more preferably 3 to 7 mg / ml, even more preferably 3 to 3. 6 mg / ml. Generally, in a liquid nutritional composition containing protein at a high concentration, gelation and aggregation are likely to occur when the sodium concentration is increased. That is, if the sodium concentration of the nutritional composition is too high, it is difficult to completely suppress gelation and aggregation even if the effects and actions of the present invention are exhibited. On the other hand, when the sodium concentration of the nutritional composition is low, gelation and aggregation are less likely to occur, but the effects and actions desired in the present invention are hardly exhibited. For this reason, it can be said that it is desirable to adjust the sodium concentration of the liquid nutritional composition to an appropriate level in consideration of the relationship with the protein concentration.
本発明において、液状栄養組成物のナトリウム濃度は、該組成物のタンパク質の濃度との比において、決定しても良い。例えば、組成物中に含まれるタンパク質1mgに対し、ナトリウム量が0.02mg、好ましくは0.02〜0.07mgの範囲であることができる。 In the present invention, the sodium concentration of the liquid nutritional composition may be determined in a ratio to the protein concentration of the composition. For example, the amount of sodium can be 0.02 mg, preferably 0.02 to 0.07 mg per 1 mg of protein contained in the composition.
本発明において、液状栄養組成物のナトリウム濃度は、熱量との関係で一定の割合となっていることが望ましい。すなわち、本発明では、熱量あたりのナトリウム濃度が2mg/kcalより高いであることが好ましい。より好ましくは2.2〜8mg/kcalであることができる。したがって、例えば熱量が1.5kcal/mlである場合、ナトリウム濃度は3mg/mlより高いことが好ましい。 In the present invention, it is desirable that the sodium concentration of the liquid nutritional composition is a constant ratio in relation to the amount of heat. That is, in the present invention, the sodium concentration per calorie is preferably higher than 2 mg / kcal. More preferably, it can be 2.2-8 mg / kcal. Therefore, for example, when the calorie is 1.5 kcal / ml, the sodium concentration is preferably higher than 3 mg / ml.
本発明による液状栄養組成物は、従来の液状栄養食品(例えば、流動食)に比べて、ナトリウムを強化するために、主要なナトリウム供給源として、有機酸のナトリウム塩を用いる。すなわち、本発明によるナトリウムを高濃度で含む組成物において、ナトリウムの高濃度化は、有機酸のナトリウム塩を添加することによって達成する。 The liquid nutritional composition according to the present invention uses a sodium salt of an organic acid as the main sodium source to enhance sodium compared to conventional liquid nutritional foods (eg, liquid foods). That is, in the composition containing sodium at a high concentration according to the present invention, the concentration of sodium is increased by adding a sodium salt of an organic acid.
ここで、前記の有機酸としては、分子内にカルボキシル基を有するもの、例えば、クエン酸、リンゴ酸、グルコン酸などが挙げられる。これらの有機酸は水溶液で、各種のミネラルイオンに対し、キレート効果を持っている。本発明では、このキレート効果により、タンパク質とミネラルイオン(ナトリウムなど)との相互作用を最小限にし、ゲル化や凝集などを抑制していると考えるが、これら説明は仮定であって本発明を限定するものではない。
よって、本発明においては、前記有機酸のナトリウム塩として、クエン酸、リンゴ酸、グルコン酸のナトリウム塩を用いることが好ましく、これらの有機酸は分子内にカルボキシル基を1個以上、2個以上、3個以上などで有するものである。本発明においてはこれらの混合物を使用しても良い。有機酸のナトリウム塩の具体例としては、クエン酸三ナトリウム、リンゴ酸二ナトリウム、グルコン酸ナトリウムなどが挙げられる。Here, as said organic acid, what has a carboxyl group in a molecule | numerator, for example, a citric acid, malic acid, gluconic acid etc. are mentioned. These organic acids are aqueous solutions and have a chelating effect on various mineral ions. In the present invention, this chelate effect is considered to minimize the interaction between protein and mineral ions (sodium, etc.) and suppress gelation and aggregation. It is not limited.
Therefore, in the present invention, it is preferable to use a sodium salt of citric acid, malic acid, or gluconic acid as the sodium salt of the organic acid, and these organic acids have one or more, two or more carboxyl groups in the molecule. 3 or more. In the present invention, these mixtures may be used. Specific examples of the organic acid sodium salt include trisodium citrate, disodium malate, and sodium gluconate.
他の成分
本発明による液状栄養組成物には、前記した以外の他の成分として、例えば、食物繊維、ビタミン類(例えば、ビタミンC、ビタミンE)、ミネラル類(例えば、亜鉛、鉄、銅、マンガンなど)、有機酸、有機塩基、果汁、フレーバー類などを単独で添加するか、または組み合わせて添加して使用することができる。また必要に応じて、さらに添加剤として、例えば、安定剤、防腐剤、湿潤剤、乳化剤、甘味料、着色料、酸化防止剤、pH調整剤などを使用しても良い。 Other components In the liquid nutritional composition according to the present invention, as other components than those described above, for example, dietary fiber, vitamins (for example, vitamin C, vitamin E), minerals (for example, zinc, iron, copper, Manganese), organic acids, organic bases, fruit juices, flavors, and the like can be added alone or in combination. If necessary, for example, stabilizers, preservatives, wetting agents, emulsifiers, sweeteners, colorants, antioxidants, pH adjusters, and the like may be used as additives.
さらに本発明の栄養組成物が医薬品用途で使用される場合には、例えば、生薬、核酸、ペプチド類、抗生物質などの併用可能な補助的有効成分を加えても良い。 Furthermore, when the nutritional composition of the present invention is used for pharmaceutical applications, for example, auxiliary active ingredients that can be used in combination such as herbal medicines, nucleic acids, peptides, and antibiotics may be added.
本発明による液状栄養組成物において、「液状」とは、本発明による組成物が、水を主成分とし、かつ、タンパク質、脂質、糖質、ナトリウムが水に溶解している水溶液であることを意味する。 In the liquid nutritional composition according to the present invention, “liquid” means that the composition according to the present invention is an aqueous solution containing water as a main component and protein, lipid, carbohydrate and sodium dissolved in water. means.
本発明による液状栄養組成物は、必要により、その平均粒径を調整しても良く、例えば、好ましい平均粒子径としては2μm以下であり、より好ましくは1.5μm以下であり、さらに好ましくは1μm以下である。 The liquid nutritional composition according to the present invention may have an average particle diameter adjusted as necessary. For example, a preferable average particle diameter is 2 μm or less, more preferably 1.5 μm or less, and further preferably 1 μm. It is as follows.
本発明による栄養組成物は、食品として提供されても、医薬品として提供されても良い。医薬品として提供される場合には、例えば、各国の法制により、医療機関において栄養補給用で使用される栄養食品様組成物や栄養補給剤が、医薬品として分類されるような場合などが包含され得る。 The nutritional composition according to the present invention may be provided as a food or a pharmaceutical product. In the case of being provided as a pharmaceutical, for example, a case where a nutritional food-like composition or nutritional supplement used for nutritional supplementation in a medical institution is classified as a pharmaceutical according to the laws of each country can be included. .
本発明の別の好ましい態様によれば、前記したように、本発明による液状栄養組成物は、食品として提供される。すなわち本発明の液状栄養組成物は、液状栄養食品組成物と言うことができる。より好ましくは、本発明による液状栄養組成物は、流動食、医療食、経腸栄養剤、または栄養補給飲食品として提供される。 According to another preferred embodiment of the present invention, as described above, the liquid nutritional composition according to the present invention is provided as a food. That is, the liquid nutritional composition of the present invention can be said to be a liquid nutritional food composition. More preferably, the liquid nutrition composition according to the present invention is provided as a liquid food, a medical food, an enteral nutrient, or a nutritional supplement food or drink.
ここで、流動食とは、患者等が噛まずに飲み込めるような流動性を有する液状の食品のことをいい、例えば、水分含量が60〜85重量%程度であって、栄養チューブでの良好な流動性を有するものをいう。そのような流動性としては、例えば、温度25℃で、落差60cmでの流下速度100ml/時間以上のような条件を満たすものが挙げられる。 Here, the liquid food means a liquid food having fluidity that can be swallowed by a patient or the like without chewing, for example, having a water content of about 60 to 85% by weight and being good in a nutrition tube. It has fluidity. Examples of such fluidity include those that satisfy the conditions such as a flow rate of 100 ml / hour or more at a temperature of 25 ° C. and a drop of 60 cm.
医療食とは、医療現場で使用される治療や予防上の観点から、患者に摂取が推奨される食品であり、必ずしも医薬品として分類されるものを意味するものではない。経腸栄養剤は、経管の栄養補給剤をいい、医薬品として分類されるものも、食品として扱われるものも包含する。 A medical food is a food that is recommended to be taken by a patient from the viewpoint of treatment and prevention used in a medical field, and does not necessarily mean a food classified as a medicine. Enteral nutrition refers to tube feeding supplements, including those classified as pharmaceuticals and those treated as food.
栄養補給飲食品には、健康食品、機能性食品、疾病リスク低減表示が付された食品等が含まれる他、病者用食品のような分類の食品も含まれる。これらの食品は、保健上の観点から、各国(例えば我が国)において法上の何らかの制限を受けることがある食品も包含される。また、疾病リスク低減表示とは、疾病リスクを低減する可能性のある食品の表示であって、FAO/WHO合同食品規格委員会(コーデックス委員会)の定める規格に基づいて、またはその規格を参考にして、定められた表示または認められた表示であることができる。 Nutritional foods and drinks include health foods, functional foods, foods with a disease risk reduction label, and the like, and foods of a classification such as foods for the sick. These foods include foods that may be subject to some legal restrictions in each country (for example, Japan) from the viewpoint of health. The disease risk reduction label is a label for foods that may reduce the disease risk, and is based on the standards established by the FAO / WHO Joint Food Standards Committee (Codex Committee) or the standards. By reference, it can be a defined display or an approved display.
製造方法
本発明による前記液状栄養組成物の製造方法は、前記したように、タンパク質と、脂質と、糖質とを含む水溶液に、有機酸のナトリウム塩を加えることによって、液状栄養組成物中のナトリウム濃度を2mg/mlより高い濃度とすることを含んでなる。この場合、例えば、有機酸のナトリウム塩を加えた後、所望の濃度の食品とするために、さらに蒸留水等を加えて、さらに希釈しても良い。また得られた調合液は、必要に応じて、ホモゲナイザー等により均質化したり、殺菌処理に付した後パッケージングしたりしても良い。 Production Method The production method of the liquid nutritional composition according to the present invention includes the addition of a sodium salt of an organic acid to an aqueous solution containing protein, lipid, and carbohydrate as described above. The sodium concentration being higher than 2 mg / ml. In this case, for example, after adding a sodium salt of an organic acid, distilled water or the like may be further diluted to obtain a food having a desired concentration. Moreover, the obtained preparation liquid may be homogenized by a homogenizer or the like, or may be packaged after being sterilized as necessary.
本発明を以下の例によって詳細に説明するが、本発明は、これらに限定されるものではない。 The present invention will be described in detail with reference to the following examples, but the present invention is not limited thereto.
実施例1
市販の流動食(「メイバランス1.5HPZ」、明治乳業株式会社製、1.5kcal/ml)を用意し、これを調合液として用いた。調合液を2分割した後に、それぞれへ蒸留水とクエン酸三ナトリウム水溶液を加えて、熱量が1kcal/mlとなるように希釈した。この時、蒸留水のみを用いて希釈した調合液のナトリウム濃度は1.1mg/ml、であった。またクエン酸三ナトリウム水溶液を用いて希釈した調合液のナトリウム濃度は2.4mg/mlであった。
これらの調合液を殺菌(間接加熱、140℃、2秒間)した後に、均質化(ホモゲナイザー、200kgf/cm2+50kgf/cm2)し、LLブリック容器(ロング・ライフ・ブリック容器)(200ml)に充填して、2種類の流動食(1kcal/ml)を製造した。 Example 1
A commercially available liquid food (“Maybalance 1.5HPZ”, manufactured by Meiji Dairies Co., Ltd., 1.5 kcal / ml) was prepared and used as a preparation. After the preparation solution was divided into two, distilled water and trisodium citrate aqueous solution were added to each to dilute the calorific value to 1 kcal / ml. At this time, the sodium concentration of the preparation diluted with only distilled water was 1.1 mg / ml. Moreover, the sodium concentration of the preparation liquid diluted with the trisodium citrate aqueous solution was 2.4 mg / ml.
Sterilize these preparations (indirect heating, 140 ° C., 2 seconds) after homogenization (homogenizer, 200kgf / cm 2 + 50kgf / cm 2) , and the LL brick container (Long Life brick container) (200 ml) Filled to produce two types of liquid food (1 kcal / ml).
得られた2種類の流動食(製品)を、室温(約20℃)、約1週間で保存した後に、その品質を確認した。
この結果、何れの製品においてもゲル化や凝集は起こらず、品質は良好であった。
液状栄養食品のナトリウムの含量(濃度)を強化するために、クエン酸三ナトリウムを用いた場合には、ナトリウム濃度が2.4mg/mlの流動食が得られたが、この流動食は、一般的な殺菌条件や均質化条件を施すことによって、比較例と同様に製造できた。すなわち、このナトリウムを高濃度で含む流動食の熱安定性や物性は良好であった。The obtained two kinds of liquid foods (products) were stored at room temperature (about 20 ° C.) for about one week, and then the quality was confirmed.
As a result, neither product gelled nor aggregated, and the quality was good.
When trisodium citrate was used to enhance the sodium content (concentration) of liquid nutritional food, a liquid food with a sodium concentration of 2.4 mg / ml was obtained. It was able to be manufactured in the same manner as the comparative example by applying typical sterilization conditions and homogenization conditions. That is, the heat stability and physical properties of the liquid food containing sodium at a high concentration were good.
実施例2
市販の流動食(「メイバランス1.5HPZ」、明治乳業株式会社製、1.5kcal/ml)を用意し、これを調合液として用いた。この調合液を、表1に示した数のサンプル用に別々の容器に分けて用意し、それぞれへ蒸留水と、表1に示した各種のナトリウム塩の水溶液を加えて、熱量が1kcal/mlとなるように希釈した。この時、蒸留水のみを用いて希釈した調合液のナトリウム濃度は1.1mg/mlであった。また、各ナトリウム塩の水溶液を用いて希釈した調合液のナトリウム濃度は、表1に示した通りであった。
これらの調合液をそれぞれソフトバッグ容器(200ml)に充填した後、レトルト殺菌(121℃、9分30秒間)して、表1に示すような16種類の流動食(1kcal/ml)を製造した。 Example 2
A commercially available liquid food (“Maybalance 1.5HPZ”, manufactured by Meiji Dairies Co., Ltd., 1.5 kcal / ml) was prepared and used as a preparation. Prepare this preparation solution separately for each sample of the number shown in Table 1, and add distilled water and aqueous solutions of various sodium salts shown in Table 1 to each sample, and the calorific value is 1 kcal / ml. It diluted so that it might become. At this time, the sodium concentration of the preparation diluted with only distilled water was 1.1 mg / ml. Moreover, the sodium concentration of the preparation liquid diluted with the aqueous solution of each sodium salt was as shown in Table 1.
Each of these preparations was filled in a soft bag container (200 ml), and then retort sterilized (121 ° C., 9 minutes 30 seconds) to produce 16 types of liquid food (1 kcal / ml) as shown in Table 1. .
得られた各流動食(製品)について、それぞれの粘度、沈殿率、および、平均粒子径を確認した。
ここで、粘度はB型粘度計(「TVB−10」、東機産業株式会社製)を用いて、室温(25℃程度)の測定条件にて測定した。
沈殿率は、沈殿物の重量を試料の全重量で除して、百分率として表した。具体的には、遠心沈降管へ試料を50gで充填し、遠心分離器(「KUBOTA−5200」、株式会社久保田製作所社製)を用いて、3000rpm、30分間で処理した後に、その沈殿物の重量を試料の全重量で除して求めた。
平均粒子径は、粒度分布計(「SALD−2000」、株式会社島津製作所製)の測定値(メジアン径)であった。About each obtained liquid food (product), each viscosity, the precipitation rate, and the average particle diameter were confirmed.
Here, the viscosity was measured using a B-type viscometer (“TVB-10”, manufactured by Toki Sangyo Co., Ltd.) under measurement conditions at room temperature (about 25 ° C.).
The precipitation rate was expressed as a percentage by dividing the weight of the precipitate by the total weight of the sample. Specifically, a sample is filled in a centrifugal settling tube with 50 g, and after processing at 3000 rpm for 30 minutes using a centrifuge (“KUBOTA-5200”, manufactured by Kubota Corporation), the precipitate The weight was determined by dividing by the total weight of the sample.
The average particle diameter was a measured value (median diameter) of a particle size distribution meter (“SALD-2000”, manufactured by Shimadzu Corporation).
結果は表1に示される通りであった。 The results were as shown in Table 1.
液状栄養食品のナトリウムの含量(濃度)を強化するために、ナトリウム塩として、硝酸ナトリウム、酒石酸ナトリウム、エリソルビン酸ナトリウム、アスコルビン酸ナトリウム、およびフマル酸二ナトリウムを用いた場合には、粘度が幾らか増加した。
いずれのナトリウム塩を用いた場合にも、沈殿率に大きな影響はなかった。
ナトリウム塩として、乳酸ナトリウム、グルタミン酸ナトリウム、プロピオン酸ナトリウム、およびコハク酸二ナトリウムを用いた場合には、平均粒子径が幾らか増加した。ナトリウム塩として、硝酸ナトリウム、酒石酸ナトリウム、エリソルビン酸ナトリウム、アスコルビン酸ナトリウム、およびフマル酸二ナトリウムを用いた場合には、平均粒子径がより増加していた。なお、平均粒子径は小さい程、物性は安定していると言える。When sodium nitrate, sodium tartrate, sodium erythorbate, sodium ascorbate, and disodium fumarate are used as sodium salts to enhance the sodium content (concentration) of liquid nutritional foods, the viscosity is somewhat Increased.
When any sodium salt was used, the precipitation rate was not significantly affected.
When sodium lactate, sodium glutamate, sodium propionate, and disodium succinate were used as sodium salts, the average particle size increased somewhat. When sodium nitrate, sodium tartrate, sodium erythorbate, sodium ascorbate, and disodium fumarate were used as sodium salts, the average particle size was further increased. It can be said that the smaller the average particle size, the more stable the physical properties.
液状栄養食品のナトリウムの含量(濃度)を強化するために、クエン酸三ナトリウム、リンゴ酸二ナトリウム、およびグルコン酸ナトリウムを用いた場合には、ナトリウム濃度が3〜6mg/mlの流動食を一般的な殺菌条件などで製造できた。そして、それらのナトリウムを高濃度で含む流動食の熱安定性や物性は良好であった。 In order to enhance the sodium content (concentration) of liquid nutritional foods, when trisodium citrate, disodium malate, and sodium gluconate are used, liquid food with a sodium concentration of 3-6 mg / ml is generally used Could be manufactured under typical sterilization conditions. And the heat stability and physical property of the liquid food which contain those sodium in high concentration were favorable.
Claims (10)
組成物中のタンパク質濃度が30〜100mg/mlであり、かつ
組成物のナトリウム濃度が2mg/mlよりも高いことを特徴とする、液状栄養組成物。A liquid nutritional composition comprising a protein, a lipid, and a carbohydrate, wherein the calorie of the composition is 1 kcal / ml or more,
A liquid nutritional composition, wherein the protein concentration in the composition is 30 to 100 mg / ml, and the sodium concentration of the composition is higher than 2 mg / ml.
タンパク質と、脂質と、糖質とを含む水溶液に、有機酸のナトリウム塩を加えることによって、液状栄養組成物中のナトリウム濃度を2mg/mlより高い濃度とすることを含んでなる、製造方法。It is a manufacturing method of the liquid nutritional composition according to claim 1,
A production method comprising adding a sodium salt of an organic acid to an aqueous solution containing a protein, a lipid, and a saccharide, so that the sodium concentration in the liquid nutritional composition is higher than 2 mg / ml.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009507517A JP5421769B2 (en) | 2007-03-30 | 2008-03-28 | Liquid nutrition composition containing sodium in high concentration and method for producing the same |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007090052 | 2007-03-30 | ||
JP2007090052 | 2007-03-30 | ||
JP2009507517A JP5421769B2 (en) | 2007-03-30 | 2008-03-28 | Liquid nutrition composition containing sodium in high concentration and method for producing the same |
PCT/JP2008/056083 WO2008120717A1 (en) | 2007-03-30 | 2008-03-28 | Liquid nutritional composition containing sodium at high concentration and method of producing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2008120717A1 true JPWO2008120717A1 (en) | 2010-07-15 |
JP5421769B2 JP5421769B2 (en) | 2014-02-19 |
Family
ID=39808297
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009507517A Active JP5421769B2 (en) | 2007-03-30 | 2008-03-28 | Liquid nutrition composition containing sodium in high concentration and method for producing the same |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP5421769B2 (en) |
KR (1) | KR101397863B1 (en) |
CN (1) | CN101652081B (en) |
HK (1) | HK1141407A1 (en) |
WO (1) | WO2008120717A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9629384B2 (en) * | 2005-09-14 | 2017-04-25 | S & P Ingredient Development, Llc | Low sodium salt composition |
JP2009284848A (en) * | 2008-05-30 | 2009-12-10 | Q P Corp | Liquid food richly containing sodium |
JP6192889B2 (en) * | 2011-10-19 | 2017-09-06 | 株式会社明治 | Preparation method for transmission electron microscope sample |
JP6098047B2 (en) * | 2012-06-27 | 2017-03-22 | 日油株式会社 | Liquid nutrition composition |
JP6347941B2 (en) * | 2013-12-04 | 2018-06-27 | テルモ株式会社 | Liquid nutrient |
JP2015107074A (en) * | 2013-12-04 | 2015-06-11 | テルモ株式会社 | Liquid nutritional supplement |
CN106307542A (en) * | 2016-08-18 | 2017-01-11 | 无锡市利贝乐贸易有限公司 | Infant plant nutritional supplement with body toxin-clearing, body function-regulating and balanced nutrition-supplementing functions and preparation method thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1107668A (en) * | 1994-12-23 | 1995-09-06 | 广州鹰金钱企业集团公司 | Nutritive liquid diet |
JP4101407B2 (en) | 1999-08-12 | 2008-06-18 | 田辺三菱製薬株式会社 | Total nutritional fluid |
JP4063022B2 (en) * | 2002-09-11 | 2008-03-19 | 日油株式会社 | Liquid food and beverage composition and food and beverage |
CN101027074B (en) * | 2004-09-22 | 2010-06-16 | 味之素株式会社 | Total enteral nutritious composition |
JP4462623B2 (en) | 2005-05-31 | 2010-05-12 | 明治乳業株式会社 | Method for producing weakly acidic milk protein-containing beverage |
-
2008
- 2008-03-28 WO PCT/JP2008/056083 patent/WO2008120717A1/en active Application Filing
- 2008-03-28 CN CN2008800107406A patent/CN101652081B/en not_active Expired - Fee Related
- 2008-03-28 KR KR1020097022718A patent/KR101397863B1/en active IP Right Grant
- 2008-03-28 JP JP2009507517A patent/JP5421769B2/en active Active
-
2010
- 2010-08-16 HK HK10107788.9A patent/HK1141407A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR101397863B1 (en) | 2014-05-20 |
HK1141407A1 (en) | 2010-11-12 |
CN101652081B (en) | 2013-06-12 |
WO2008120717A1 (en) | 2008-10-09 |
KR20100016068A (en) | 2010-02-12 |
JP5421769B2 (en) | 2014-02-19 |
CN101652081A (en) | 2010-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6098047B2 (en) | Liquid nutrition composition | |
JP5421769B2 (en) | Liquid nutrition composition containing sodium in high concentration and method for producing the same | |
JP5779348B2 (en) | Acidic liquid nutritional composition | |
JP5632112B2 (en) | Semi-solidified nutrient | |
US9872515B2 (en) | Low-concentration nutritional composition | |
RU2598630C2 (en) | Liquid nutritional composition comprising free amino acids | |
JP6277957B2 (en) | Nutritional composition | |
JP2007126379A (en) | Method for producing acidic liquid enteral nutritive preparation | |
CN107440088A (en) | Improve operation, the nutrients and preparation method thereof of chemicotherapy tumor patient immunity | |
JP5384333B2 (en) | Liquid nutritional composition containing whey protein at high concentration and method for producing the same | |
JP2015509955A (en) | High energy liquid nutritional composition with improved sensory properties | |
JP5902815B2 (en) | Acid liquid nutrient | |
JPWO2015146460A1 (en) | Liquid nutrition composition | |
JP2008301723A (en) | Emulsified multiple nutritious food | |
JP5402921B2 (en) | Concentrated liquid food containing soy protein | |
JP2014193822A (en) | Thickened nutritive composition | |
JP5665009B2 (en) | Liquid emulsified nutritional composition | |
JP2009261361A (en) | Thick liquid food containing vegetable protein | |
JP6083962B2 (en) | Acid-resistant liquid nutritional composition | |
WO2013132670A1 (en) | Semi-solidified nutritive agent | |
JP2023069186A (en) | Nutritive composition, manufacturing method of nutritive composition, and evaluation method of bioavailability of copper in nutritive composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110217 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20121116 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121227 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20130109 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20130618 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130904 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20130926 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20131112 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20131122 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5421769 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |